GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3126 - 3150 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgG Patient 1 6 moderate
G17689EW
122
IgM Patient 1 10 moderate
G17689EW
50
IgM Patient 1 22 moderate
G17689EW
85
IgM Patient 1 6 moderate
G17689EW
48
IgA Patient 2 15 mild
G17689EW
636
IgA Patient 2 24 mild
G17689EW
693
IgG Patient 2 15 mild
G17689EW
109
IgG Patient 2 24 mild
G17689EW
112
IgM Patient 2 15 mild
G17689EW
982
IgM Patient 2 24 mild
G17689EW
1054
IgA Patient 2 3 mild
G17689EW
366
IgG Patient 2 3 mild
G17689EW
48
IgM Patient 2 3 mild
G17689EW
176
IgA Patient 3 -180 mild
G17689EW
2705
IgA Patient 3 11 mild
G17689EW
2625
IgG Patient 3 -180 mild
G17689EW
937
IgM Patient 3 -180 mild
G17689EW
8401
IgA Patient 3 4 mild
G17689EW
2358
IgG Patient 3 11 mild
G17689EW
1019
IgG Patient 3 4 mild
G17689EW
849
IgM Patient 3 11 mild
G17689EW
8331
IgM Patient 3 4 mild
G17689EW
7373
IgA Patient 4 12 mild
G17689EW
4321
IgG Patient 4 12 mild
G17689EW
4126
IgM Patient 4 12 mild
G17689EW
8024

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024